| Prev Close | 226.87 |
| Open | 227.30 |
| Day Low/High | 225.59 / 230.21 |
| 52 Wk Low/High | 197.47 / 306.08 |
| Volume | 940.19K |
Vertex Pharmaceuticals Incorporated (VRTX)
228.32
1.45
0.64
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 260.04B |
| Market Cap | 58.95B |
| P/E Ratio | 22.20 |
| Div & Yield | N.A. (N.A) |
Looking at Four Biotechs
Here is my take on some questions from readers.
Don't Ignore Earnings Plays
Because of Europe, the market has turned a deaf ear toward earnings season.
Forget About Europhoria
The euro/dollar cross foretold yesterday's big rally, but individual stocks' action amid the broad upswing could be telling.
Playing Vertex Into Earnings
The chart and the CEO tell very different stories about the drugmaker. Which one is right?
